Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (0)
  • 2024 (1)
  • 2022 (1)
  • 2019 (3)
  • 2018 (10)

Subject

  • Drug Trafficking (242)
  • Synthetic drugs (65)
  • Arrests/Convictions - Major (64)
  • OCDETF/Task Force (62)
  • Fake Pills (61)
  • Guns/Weapons (53)
  • Guilty Plea (33)
  • Gangs (17)
  • Fentanyl Awareness (16)
  • Overdose (16)
  • Prescription Drugs (16)
  • Seizures (Drugs/Property) (16)
  • Money Laundering (15)
  • Take Back Day (14)
  • Diversion Division (10)
  • Major Law Enforcement Operation (10)
  • One Pill Can Kill (7)
  • Pharmaceuticals/Pharmacists/Physicians (7)
  • Extraditions (6)
  • Press Conferences (6)
  • HIDTA (5)
  • Outreach/Drug Prevention (3)
  • Prevention/Education - DEA websites GSAD, JTT etc (3)
  • Public and Media Affairs - also see Congressional Affairs (3)
  • Task Forces/Task Force Officers (3)
  • Intelligence Division - Intelligence Products (2)
  • Critical Incident (1)
  • Dark Web- Internet Trafficking (1)
  • International/Foreign Operations (1)
  • Narcoterrorism (1)
  • Red Ribbon (1)
  • Terrorism (1)
  • Congressional Affairs (10)

Drug Name

  • Synthetic Opioids (3)
  • Fentanyl (1)

Field Division

  • Headquarters (9)
  • Louisville (1)
Clear All Results
PRESS RELEASE

DEA releases 2018 National Drug Threat Assessment

November 02, 2018
WASHINGTON – DEA Acting Administrator Uttam Dhillon today announced results of the 2018 National Drug Threat Assessment, which outlines the threats posed to the United States by domestic and international drug trafficking and the abuse of illicit drugs. “This report underscores the scope and magnitude of the ongoing opioid crisis...
November 02, 2018
PRESS RELEASE

DEA acts against dangerous, deadly designer synthetic drug linked to 151 overdose deaths since 2015

August 31, 2018
WASHINGTON – The Drug Enforcement Administration today announced action against a dangerous designer synthetic cathinone linked to 151 overdose deaths in the United States between 2015 and 2018. Published in today’s Federal Register, DEA’s action puts N-Ethylpentylone into Schedule I of the Controlled Substances Act. Schedule I substances refer to...
August 31, 2018
PRESS RELEASE

DEA investigators seeking answers in small Tennessee town

August 28, 2018
CELINA, Tenn. -- DEA investigators this week conducted inspections at several pharmacy locations in the Clay County, Tennessee town of Celina, following an inquiry into irregular patterns of pill purchases from drug distribution companies. DEA is now investigating possible criminal activity involving the illicit diversion of controlled prescription pharmaceuticals at...
August 28, 2018
PRESS RELEASE

Justice Department, DEA propose significant opioid manufacturing reduction in 2019

August 16, 2018
WASHINGTON – The Department of Justice and U.S. Drug Enforcement Administration have proposed a reduction for controlled substances that may be manufactured in the U.S. next year. Consistent with President Trump’s “Safe Prescribing Plan” that seeks to “cut nationwide opioid prescription fills by one-third within three years,” the proposal decreases...
August 16, 2018
PRESS RELEASE

Department of Justice announces regulatory steps to address opioid epidemic

July 11, 2018
WASHINGTON – The Department of Justice today announced the finalization of an April proposal to improve the Drug Enforcement Administration’s ability to control the diversion of dangerous drugs in the midst of the national opioid crisis. Announced in April by Attorney General Jeff Sessions, the final rule sent for publication...
July 11, 2018
PRESS RELEASE

Senior Sinaloa Cartel leader extradited to the United States

July 06, 2018
WASHINGTON –Mexican authorities today extradited Sinaloa Cartel leader Damaso Lopez Nuñez, also known as “El Licenciado,” to the United States to face drug trafficking charges filed in the Eastern District of Virginia. Acting Assistant Attorney General John P. Cronan of the Justice Department’s Criminal Division; U.S. Attorney G. Zachary Terwilliger...
July 06, 2018
PRESS RELEASE

Attorney General Jeff Sessions Announces Uttam Dhillon as New Acting Administrator Of Drug Enforcement Administration

July 02, 2018
WASHINGTON – Today, Attorney General Jeff Sessions announced the appointment of Uttam Dhillon as Acting Administrator of the Drug Enforcement Administration. Dhillon will replace Robert Patterson, who has retired after 30 years of service. "With one American dying of a drug overdose every nine minutes, there can be no doubt...
July 02, 2018
PRESS RELEASE

National Health Care Fraud Takedown Results in Charges against 601 Individuals Responsible for over $2 Billion in Fraud Losses

June 28, 2018
WASHINGTON – Attorney General Jeff Sessions and Department of Health and Human Services (HHS) Secretary Alex M. Azar III, announced today the largest ever health care fraud enforcement action involving 601 charged defendants across 58 federal districts, including 165 doctors, nurses and other licensed medical professionals, for their alleged participation...
June 28, 2018
PRESS RELEASE

Fugitive Wanted For The Kidnapping And Murder Of A Federal Agent Is Added To The FBI’s “Ten Most Wanted Fugitives” List

April 12, 2018
WASHINGTON - Federal Bureau of Investigation Deputy Director David L. Bowdich, Drug Enforcement Administration Acting Administrator Robert W. Patterson, U.S. Department of State Deputy Assistant Secretary James Walsh, and U.S. Marshals Service Acting Associate Director Derrick Driscoll today announced the addition of fugitive Rafael Caro-Quintero to the FBI’s list of...
April 12, 2018
PRESS RELEASE

DEA announces the establishment of a new Division Office in Omaha

March 07, 2018
(OMAHA, Neb.) – The Drug Enforcement Administration will establish the Omaha Field Division – its 23rd division office in the United States – on July 8, 2018. The division will include Nebraska, Iowa, Minnesota, North Dakota and South Dakota. “This action converts the existing Omaha District Office into a division...
March 07, 2018
Showing 1 - 10 of 10 results

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster

United States Drug Enforcement Administration

Back
  • Who We Are
  • What We Do
  • Careers
  • Resources
Back
  • About
  • Mission
  • History
  • Divisions
  • DEA Museum
  • Wall of Honor
  • Contact Us
Back
  • Domestic Divisions
  • Foreign Divisions
  • Operational Divisions
Back
  • Submit a Tip
  • Extortion Scam
  • Public Affairs
  • Social Media Directory
Back
  • Forensic Sciences
  • Law Enforcement
  • Education and Prevention
  • Drug Information
  • News
  • Campaigns
Back
  • GUARDS
  • Forensic Sciences Policy
  • Forensic Science Organizations
  • Forensic Science Contact
Back
  • DEA Office of Training
  • El Paso Intelligence Center (EPIC)
  • Intelligence
  • Operations
Back
  • Office of Training Programs
Back
  • Administrative Law Judges
  • DEA Asset Forfeiture
  • Domestic Cannabis Suppression / Eradication Program
  • HIDTA
  • OCDETF
Back
  • Family Summit
  • Red Ribbon
  • Kiki and the History of Red Ribbon Week
  • Red Ribbon Toolkit - Resources For Your Community
  • DEA’s Family Summit
  • Operation Engage
  • Community Outreach
  • Just Think Twice
  • Campus Drug Prevention
  • Get Smart About Drugs
  • Operation Prevention
Back
  • Drug Policy
  • Drug Scheduling
  • The Controlled Substances Act
Back
  • Alerts
  • Press Releases
  • Most Wanted Fugitives
  • Stories
  • Events
  • Speeches
  • Testimony
Back
  • All Fugitives
Back
  • One Pill Can Kill
  • DEA National Prescription Drug Take Back Day
Back
  • Senior Citizens
  • Partner Toolbox
  • Social Media Campaign
Back
  • Special Agent
  • Diversion Investigator
  • Intelligence Research Specialist
  • Forensic Sciences Careers
  • Professional & Administrative Careers
  • Student & Entry Level Careers
  • Employment Eligibility
  • How to Apply
Back
  • Special Agent FAQs
Back
  • Diversion Investigator Job Announcement
Back
  • Intelligence Research Specialist Job Announcements
  • Intelligence Research Specialists FAQs
  • Schedule A Hiring Authority: Intelligence Research Specialist
Back
  • How To Claim Veterans' Preference
  • Priority Consideration
  • Benefits
  • Veterans and People With Disabilities
  • Operation Warfighter
Back
  • Illegal Online Pharmacies
  • OD Justice
  • Fentanyl Supply Chain
  • Pill Press Resources
  • Recovery Resources
  • Together for Families
  • Data and Statistics
  • FOIA
  • Publications
  • Media Galleries
  • Victim Witness Assistance Program
Back
  • Domestic Arrests
  • Staffing and Budget
Back
  • About FOIA
  • Contact DEA FOIA
  • Make a Request
  • What Happens After Making a Request
  • Requester Categories
  • Fees Charged
  • Fee Waiver
  • FOIA FAQ
  • FOIA Logs and Reports
  • FOIA Library
  • Additional FOIA Links
  • FOIA Exemptions
  • What Are Exclusions?
  • Privacy Act
  • Privacy Act Exemptions
  • Privacy Impact Assessment and Management Information Systems
Back
  • Victim Witness Assistance Program Resources
  • Human Trafficking Prevention
  • Submit A Tip +
  • Get Updates
  • Scam Alert
    • English
    • Español